gtmagency
×
Previously ran growth for 500+ SaaS companies through their product launches. Our team has also worked with companies backed by
This playbook maps Paxel's ideal customer profile across account, prospect, and persona dimensions, then lays out 5 signal-based outbound plays. Each play fires on a specific buying signal so your outreach lands the moment a prospect is most likely to act.
| Dimension | Qualified | Prioritization |
|---|---|---|
| Geography | United States (primary), Canada (secondary) | Prioritize US-based manufacturers with direct health system sales teams |
| Employee Count | 50 to 2,000 employees | Sweet spot is 100 to 800 employees where sales ops pain is acute but budget exists |
| Industry / Vertical | Generic drug manufacturers, 503B outsourcing vendors, biosimilar manufacturers, branded pharma commercial teams | Prioritize generic and 503B segments first given price/volume sensitivity messaging fit |
| Key Qualifying Signal | Sales rep headcount of 10 or more managing IDN, GPO, or health system contracts with evidence of fragmented CRM or manual data workflows | Highest priority if reps spend documented time on non-selling admin or company uses multiple disconnected data tools |
| Tech Stack | Veeva CRM, Salesforce, IQVIA, Symphony Health, legacy spreadsheet workflows, QuintilesIMS | Prioritize accounts running Veeva or Salesforce alongside IQVIA or Symphony Health (signals data fragmentation) |
| Revenue / Funding | $10M to $500M annual revenue, or Series A and above funding | Prioritize profitable generics and funded biosimilar players with commercial infrastructure |
| Intent Signals | Hiring for commercial analytics, sales ops, or CRM roles; attending NACDS, ASHP, or eyeforpharma events; publishing RFPs for sales intelligence tools | Highest intent if actively hiring sales ops or evaluating CRM/data consolidation tools |
| Dimension | Qualified | Prioritization |
|---|---|---|
| Seniority | VP and above for economic buyer; Director and Manager for champion | VP Commercial, VP Sales Operations, or Chief Commercial Officer as economic buyer; Director of Sales Analytics as champion |
| Primary Titles | VP of Sales Operations, VP of Commercial Excellence, Chief Commercial Officer, VP of Market Access, Director of Sales Analytics | VP of Sales Operations and VP of Commercial Excellence are highest-conversion titles |
| Secondary Influencers | VP of Marketing, Director of Managed Care, Head of Business Intelligence, IT Director (pharma), CFO at smaller manufacturers | Engage Director of Managed Care and Head of BI as technical validators |
| LinkedIn Keywords | pharma sales operations, IDN contracting, GPO strategy, health system accounts, commercial analytics, Veeva CRM, specialty pharma sales, market access analytics, sales force effectiveness | Prioritize profiles with IDN contracting and sales force effectiveness as explicit skills or job history keywords |
| Persona | Level | KPIs | Related Challenges | Intent Signals | Related Benefits |
|---|---|---|---|---|---|
| VP of Sales Operations | VP | Rep selling time percentage, CRM data quality score, forecast accuracy, sales cycle length | Reps spending 70% of time on admin, fragmented CRM and data tools, poor visibility into IDN account relationships | Hiring for sales ops or CRM roles, posting jobs mentioning Veeva or data consolidation, attending pharma sales ops conferences | Eliminates data fragmentation, automates rep workflows, increases selling time and improves forecast accuracy |
| Chief Commercial Officer | C-Suite | Revenue growth, market share by account segment, contract win rate, margin protection | Inability to detect competitor pricing moves or volume shifts in real time, lack of IDN relationship visibility, lost margin from missed signals | Speaking at industry events about commercial transformation, company posting CCO or VP Commercial job openings, recent funding round | Provides real-time pricing and volume shift detection, maps IDN and health system relationships, protects margin and captures volume |
| Director of Sales Analytics | Director | Data pipeline uptime, report turnaround time, accuracy of market data, adoption of analytics tools by reps | Building and maintaining fragmented data pipelines, reconciling IQVIA and internal CRM data, low rep adoption of current tools | Job posting for data engineer or analytics manager, LinkedIn posts about pharma data quality, evaluating BI tools | Fusion.ai unifies proprietary and external pharma data, eliminates manual reconciliation, improves rep adoption through actionable insights |
| VP of Market Access | VP | Contract win rate with IDNs and GPOs, formulary placement, net revenue per account, pull-through rate | Poor visibility into which health system relationships drive purchase decisions, slow response to formulary changes, disconnected contracting data | Hiring managed care analysts, attending PCMA or market access summits, posting about IDN strategy on LinkedIn | Pulse.ai maps IDN and health system account hierarchies, surfaces where purchase decisions are made, accelerates contract pull-through |
| Head of Business Intelligence | Director/Manager | Data accuracy, time to insight, cost of data vendors, self-serve analytics adoption | Juggling multiple data vendor contracts, duplicate or conflicting data sources, high cost of maintaining legacy data infrastructure | Posting RFPs for data platforms, evaluating Symphony Health or IQVIA alternatives, hiring BI developers | Single platform replaces multiple data vendors, no painful implementation, AI-powered data management reduces BI team overhead |
When a pharma manufacturer is actively hiring for sales ops or analytics roles, they are signaling pain with their current data and CRM infrastructure. We reach out to the VP of Sales Operations or CCO with a message tied directly to the hiring signal.
Monitor Job Postings
Aggregate Hiring Signals
Enrich Account Data
Find Decision Makers
Identify Buying Committee
Email
LinkedInPharma companies running Veeva alongside IQVIA or Symphony Health are paying for duplicate, disconnected data that reps cannot action. We target VP Sales Ops and Directors of Analytics with a consolidation and cost-reduction message.
Cross-Reference Stack
Build Account List
Enrich Company Profile
Find Buying Committee
Email
LinkedInConference attendance by commercial pharma leaders is a high-intent buying signal. We scrape attendee and speaker lists, enrich them against our ICP, and launch a timely sequence before and after the event with messaging tied to conference themes.
Scrape Attendee Lists
Aggregate Event Leads
Enrich Attendee Profiles
Validate Account Fit
Identify Buying Committee
Email
LinkedInWhen a champion who knows Paxel's platform takes a new role at a qualified pharma company, they carry institutional knowledge and familiarity. We alert on these moves immediately and reach out with a warm, context-rich message before their new company's tool evaluation begins.
Track Champion Job Changes
Enrich New Account
Find Additional Stakeholders
Identify Buying Committee
Email
LinkedInPublic LinkedIn posts about pharma data pain and rep productivity are real-time buying signals from decision makers who are actively seeking solutions. We monitor these signals, identify the poster's company fit, and reach out with a message that mirrors their stated problem.
Monitor LinkedIn Posts
Scrape Post Engagers
Aggregate Signals
Enrich Poster Profile
Verify Company ICP Fit
Buying Committee
LinkedInYou'll have qualified demos booked in your calendar within 45 days: infrastructure, sequences, and live campaigns installed for you.
You don't pay a retainer. Everything we build belongs to you from day one: data, playbooks, and infrastructure.
If by day 45 you aren't seeing qualified demos booked in your calendar, we keep working completely for free until you do.
We build and install a fully automated, signal-based outbound system, outbound, ads, and content, in a 45-day sprint. No retainer, and you own everything. Demos booked in 45 days or we work free until they are.